日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Serum adipsin levels in rheumatic diseases: defining its role in disease activity and progression in rheumatoid arthritis and axial spondyloarthritis.

风湿性疾病中血清脂肪素水平:确定其在类风湿性关节炎和中轴型脊柱关节炎的疾病活动和进展中的作用

Novella-Navarro Marta, González-Sánchez Laura, Hernández-Breijo Borja, Pérez De Diego Rebeca, Sánchez-Corral Pilar, López-Trascasa Margarita, Miranda-Carús Maria-Eugenia, Villalba Alejandro, Balsa Alejandro, De Miguel Eugenio, Plasencia-Rodríguez Chamaida, Corvillo Fernando

Do Obesity and Adipose Tissue Cytokines Influence the Response to Janus Kinase Inhibitors in Rheumatoid Arthritis?

肥胖和脂肪组织细胞因子是否会影响类风湿性关节炎患者对 Janus 激酶抑制剂的反应?

Novella-Navarro, Marta; Van Den Rym, Ana; López-Pedrera, Chary; Martínez-Feito, Ana; Nieto-Carvalhal, Beatriz; Reche, Keren; López-Medina, Clementina; Escudero-Contreras, Alejandro; Nozal, Pilar; Miranda-Carús, Maria Eugenia; Monjo, Irene; De Miguel, Eugenio; Balsa, Alejandro; Pérez-De Diego, Rebeca; Plasencia-Rodríguez, Chamaida

Early-onset difficult-to-treat rheumatoid arthritis: proposal of data-driven predictors and temporal threshold

早发性难治性类风湿性关节炎:数据驱动预测因子和时间阈值的提出

Rodriguez-Merlos, Pablo; Cabrera-Alarcón, Jose Luis; Ruiz-Esquide, Virginia; Chacur, Chafik Alejandro; Sanmartí, Raimon; De Miguel-Mendieta, Eugenio; Álvaro-Gracia, Jose María; Balsa, Alejandro; Plasencia-Rodríguez, Chamaida; Novella-Navarro, Marta

Early monitoring of anti-infliximab antibodies by drug-tolerant assay predicts later immunogenicity and drug survival in rheumatic diseases

通过耐药性试验早期监测抗英夫利昔单抗抗体,可预测风湿性疾病患者后期的免疫原性和药物存活率。

Martínez-Feito, Ana; Novella-Navarro, Marta; Hernández-Breijo, Borja; Nozal, Pilar; Peiteado, Diana; Villalba, Alejandro; Nuño, Laura; Monjo, Irene; Pascual-Salcedo, Dora; Balsa, Alejandro; Plasencia-Rodríguez, Chamaida

Exosomal Protein Biomarkers in Arthritis: Deciphering the Inflammatory Profiles of RA and OA

关节炎中的外泌体蛋白生物标志物:解读类风湿关节炎和骨关节炎的炎症特征

Brenis Gómez, Claudia M; Plasencia-Rodríguez, Chamaida; Novella-Navarro, Marta; Martínez-Feito, Ana; Balsa, Alejandro; Calvo-Aranda, Enrique; Hernández-Breijo, Borja

Digital Health Intervention for Patient Monitoring in Immune-Mediated Inflammatory Diseases: Cocreation and Feasibility Study of the IMIDoc Platform

针对免疫介导炎症性疾病患者监测的数字化健康干预:IMIDoc平台的共同创建和可行性研究

Benavent, Diego; Iniesta-Chamorro, Jose M; Novella-Navarro, Marta; Pérez-Martínez, Miguel; Martínez-Sánchez, Nuria; Kaffati, Mónica; Juárez-García, Manuel; Molinari-Pérez, Marina; González-Torbay, Andrea; Gutiérrez, Mariana; López-Juanes, Natalia; Navarro-Compán, Victoria; Monjo-Henry, Irene; Rodríguez-Rosales, Germán; Bachiller, Javier; Calvo-Aranda, Enrique; Michelena, Xabier; Berbel-Arcobé, Laura; Balsa, Alejandro; Gómez, Enrique J; Plasencia-Rodríguez, Chamaida

Exploring candidate biomarkers for rheumatoid arthritis through cardiovascular and cardiometabolic serum proteome profiling

通过心血管和心血管代谢血清蛋白质组分析探索类风湿性关节炎的候选生物标志物

Cuesta-López, Laura; Escudero-Contreras, Alejandro; Hanaee, Yas; Pérez-Sánchez, Carlos; Ruiz-Ponce, Miriam; Martínez-Moreno, Julio Manuel; Pérez-Pampin, Eva; González, Antonio; Plasencia-Rodriguez, Chamaida; Martínez-Feito, Ana; Balsa, Alejandro; López-Medina, Clementina; Ladehesa-Pineda, Lourdes; Rojas-Giménez, Marta; Ortega-Castro, Rafaela; Calvo-Gutiérrez, Jerusalem; López-Pedrera, Chary; Collantes-Estévez, Eduardo; Arias-de la Rosa, Iván; Barbarroja, Nuria

Exploring the influence of baseline rheumatoid factor levels on TNF inhibitor retention rate in patients with rheumatoid arthritis: a multicentre and retrospective study

探讨基线类风湿因子水平对类风湿关节炎患者TNF抑制剂维持率的影响:一项多中心回顾性研究

López-Medina, Clementina; Calvo-Gutiérrez, Jerusalem; Ábalos-Aguilera, M Carmen; Cepas, Francisco; Plasencia-Rodríguez, Chamaida; Martínez-Feito, Ana; Balsa, Alejandro; Faré-García, Regina; Juan-Mas, Antoni; Ruiz-Esquide, Virginia; Sainz, Luis; Díaz-Torné, César; Godoy-Navarrete, Francisco Javier; Añón-Oñate, Isabel; Mena-Vázquez, Natalia; Manrique-Arija, Sara; Moreno-García, Marina Soledad; Ortega-Castro, Rafaela; Escudero-Contreras, Alejandro

Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis

高类风湿因子水平对类风湿关节炎患者接受赛妥珠单抗和阿达木单抗治疗疗效的影响

Smolen, Josef S; Taylor, Peter C; Tanaka, Yoshiya; Takeuchi, Tsutomu; Hashimoto, Motomu; Cara, Carlos; Lauwerys, Bernard; Tilt, Nicola; Ufuktepe, Baran; Xavier, Ricardo M; Balsa, Alejandro; Curtis, Jeffrey R; Mikuls, Ted R; Weinblatt, Michael

What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?

我们从 RA 中抑制 IL-6 学到了什么?对改善患者预后有哪些临床机会?

Taylor, Peter C; Feist, Eugen; Pope, Janet E; Nash, Peter; Sibilia, Jean; Caporali, Roberto; Balsa, Alejandro